Orders and sales for the first quarter of 2024 decreased compared to a strong first quarter in 2023, reflecting inventory destocking by our customers, mainly in Meeting Experience and Healthcare, and softer demand in the Entertainment markets.
Orders were down 23% year-over-year with each division reporting lower orders. EMEA reported the largest decline, driven by Meeting Experience due to inventory destocking by major customers, and by softer demand in Entertainment, partly linked to a weak movie slate in Cinema. In Americas double digit order growth in Enterprise stood in contrast with a reduction in orders in Entertainment, where we saw lower order intake for Cinema-as-a-Service compared to last year. In APAC, orders were essentially flat for Enterprise, but were lower for Healthcare and Entertainment. With a positive book-to-bill ratio, the orderbook for the Group strengthened to 524.8 million euro.
Sales declined 21% versus the same quarter last year, led by EMEA. In Americas, sales declined primarily in Entertainment, while Diagnostic Imaging and Control Rooms grew. In EMEA the sales decline was driven by customers working off above average inventory levels in Meeting Experience and Healthcare and by soft demand in Entertainment, both in Cinema and Immersive Experience. APAC was also impacted by the inventory correction in Healthcare and by soft demand in Immersive Experience.
Quote of the CEO's, An Steegen & Charles Beauduin
“The first quarter of 2024 was marked by an anticipated inventory destocking by our customers in Meeting Experience and Healthcare, which is expected to be largely completed by mid-year. In Entertainment, demand was hampered by the aftermath of the strikes in the North-American film industry, and customers delaying orders in anticipation of our new product launches. Barco has a broad funnel of new product introductions in all its divisions, which form a solid foundation for resumption of our growth from the second semester. We continue to invest in our innovation pipeline of breakthrough visualization technologies in preparation for more new product introductions in 2025. We also continue to strengthen our competitive cost position through our focused factories strategy, including the opening of the new Entertainment plant in China, which is due to start commercial production in the second quarter.”
Outlook 2024
The following statements are forward looking on a like-for-like basis and actual results may differ materially
In 2024, there is continued macro-economic and market condition uncertainty, which is reducing our visibility. We assume a return to normalized customer inventory levels, and we are on track with the planned new product launches over the course of the year.
Management expects topline for the full year to be in line with 2023, with year-over-year growth resuming in the second half of the year. From 2025, we expect topline growth on a full year basis.
The EBITDA margin is expected to be above 14% for the full year 2024.